LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

Search

Penumbra Inc

Cerrado

SectorSanidad

320.7 0.4

Resumen

Variación precio

24h

Actual

Mínimo

319.37

Máximo

321.56

Métricas clave

By Trading Economics

Ingresos

163M

33M

Ventas

-11M

375M

P/B

Media del Sector

73.491

49.888

BPA

0.82

Margen de beneficios

8.695

Empleados

4,700

EBITDA

-30M

38M

Recomendaciones

By TipRanks

Recomendaciones

Neutral

Estimación a 12 Meses

+12.17% upside

Dividendos

By Dow Jones

Próximas Ganancias

28 jul 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-224M

13B

Apertura anterior

320.3

Cierre anterior

320.7

Noticias sobre sentimiento de mercado

By Acuity

50%

50%

155 / 344 Clasificación en Healthcare

Penumbra Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

15 ene 2026, 13:29 UTC

Adquisiciones, fusiones, absorciones

Boston Scientific to Buy Penumbra for $15 Billion in Cash, Stock -- 2nd Update

15 ene 2026, 12:35 UTC

Adquisiciones, fusiones, absorciones

Boston Scientific to Buy Penumbra for $15 Billion in Cash, Stock -- Update

15 ene 2026, 12:29 UTC

Adquisiciones, fusiones, absorciones

Boston Scientific to Buy Penumbra for $15 Billion in Cash, Stock

6 may 2026, 20:15 UTC

Ganancias

Penumbra Not Be Providing Fincl Guidance Due to Pending Acquisition by Boston Scientific >PEN

6 may 2026, 20:07 UTC

Ganancias

Penumbra 1Q Rev $374.8M >PEN

6 may 2026, 20:07 UTC

Ganancias

Penumbra 1Q EPS 82c >PEN

25 feb 2026, 18:02 UTC

Ganancias

Penumbra: Won't Be Providing Financial Guidance for 2026, Citing Proposed Boston Scientific Deal

25 feb 2026, 18:01 UTC

Ganancias

Penumbra 4Q Rev $385.4M >PEN

25 feb 2026, 18:01 UTC

Ganancias

Penumbra 4Q Adj EPS $1.18 >PEN

25 feb 2026, 18:01 UTC

Ganancias

Penumbra 4Q EPS $1.20 >PEN

24 ene 2026, 06:18 UTC

Adquisiciones, fusiones, absorciones

Our Boston Scientific Pick Has Stumbled. Acquiring Penumbra Will Help the Stock. -- Barrons.com

15 ene 2026, 14:37 UTC

Acciones populares

Stocks to Watch Thursday: Goldman Sachs, Boston Scientific, BlackRock -- WSJ

15 ene 2026, 13:45 UTC

Adquisiciones, fusiones, absorciones

Penumbra Stock Jumps. It's Being Bought by Boston Scientific for $14.5 Billion. -- Barrons.com

15 ene 2026, 12:04 UTC

Adquisiciones, fusiones, absorciones

Boston Scientific: Penumbra Shareholders Can Elect to Receive Cash or Stock >BSX PEN

15 ene 2026, 12:03 UTC

Adquisiciones, fusiones, absorciones

Boston Scientific: Acquisition to Expand Cardiovascular Portfolio >BSX PEN

15 ene 2026, 12:01 UTC

Adquisiciones, fusiones, absorciones

Boston Scientific: Penumbra Deal Carriers an Enterprise Value of About $14.5 Billion >BSX

15 ene 2026, 12:00 UTC

Adquisiciones, fusiones, absorciones

Boston Scientific to Buy Penumbra for $374/Share >BSX PEN

15 ene 2026, 12:00 UTC

Adquisiciones, fusiones, absorciones

Boston Scientific Announces Agreement To Acquire Penumbra, Inc. >BSX PEN

Comparación entre iguales

Cambio de precio

Penumbra Inc previsión

Precio Objetivo

By TipRanks

12.17% repunte

Estimación a 12 Meses

Media 358.25 USD  12.17%

Máximo 374 USD

Mínimo 335 USD

De acuerdo con 4 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Penumbra Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Neutral

4 ratings

1

Comprar

3

Mantener

0

Vender

Sentimiento

By Acuity

155 / 344 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Neutral

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Penumbra Inc

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers an immersive 3D computer-based technology platform under the real immersive system brand; and neurosurgical tools, such as Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.